Workflow
限制性股票激励计划
icon
Search documents
浙江哈尔斯真空器皿股份有限公司关于2020年限制性股票激励计划预留授予部分第三个解除限售期解除限售股份上市流通的提示性公告
Core Viewpoint - The company has announced the lifting of restrictions on 652,000 shares from its 2020 restricted stock incentive plan, which will be tradable starting January 13, 2026, following the fulfillment of the necessary conditions for the third lifting period [2][21]. Group 1: Incentive Plan Overview - The company approved the 2020 restricted stock incentive plan on October 16, 2020, during the second meeting of the fifth board of directors [3]. - The plan included a total of 907.50 million shares granted to 116 eligible participants at a price of 2.90 yuan per share [5]. - The first lifting period for the restricted shares was completed on January 13, 2023, allowing for the trading of shares for eligible participants [12][21]. Group 2: Lifting of Restrictions - The third lifting period for the reserved grant of restricted shares has been achieved, allowing 12 eligible participants to lift restrictions on 652,000 shares, which represents 0.1398% of the company's total share capital [2][21]. - The lifting of restrictions is scheduled for January 13, 2026, and is based on the completion of the required conditions as per the incentive plan [21]. Group 3: Changes in Share Structure - The company will adjust the repurchase price of restricted shares from 2.90 yuan to 2.75 yuan due to the completion of the 2021 annual equity distribution [10]. - The repurchase of shares from participants who have left the company has been conducted, with a total of 86,000 shares repurchased at a price of 2.90 yuan per share [7][10]. Group 4: Legal and Compliance - The company has ensured compliance with relevant laws and regulations regarding the incentive plan and has disclosed necessary legal opinions from its legal counsel [22].
苏州市世嘉科技股份有限公司第五届董事会第十三次会议决议公告
Group 1 - The company held its 13th meeting of the 5th Board of Directors on January 8, 2026, with all 6 directors present, complying with relevant regulations [1][2][3]. - The board approved the proposal regarding the execution of daily related transactions for 2025 and the expected transactions for 2026, which will be submitted to the first extraordinary shareholders' meeting of 2026 for review [5][9]. - The board also approved the proposal to repurchase and cancel part of the restricted stock from the 2024 incentive plan, which will also be submitted to the shareholders' meeting for approval [5][26]. Group 2 - The company recognized Japan Electric as a related party due to its significant shareholding in a subsidiary, leading to the classification of transactions between them as related transactions [9][16]. - The company also identified Annuode Technology and Enyipu as related parties due to their ownership structures and business relationships, necessitating the confirmation and estimation of related transactions [10][11][22]. - The independent directors unanimously agreed on the related transactions with Japan Electric and Annuode Technology, while one director recused himself from the vote on Enyipu due to a conflict of interest [12][24]. Group 3 - The company plans to hold the first extraordinary shareholders' meeting on January 26, 2026, to discuss the proposals approved by the board [43][50]. - The meeting will be conducted both in-person and via online voting, ensuring compliance with relevant regulations [44][45]. - Shareholders must register for the meeting by January 23, 2026, and can participate either in person or through a proxy [51][52].
中重科技:第二届董事会第十二次会议决议公告
Zheng Quan Ri Bao· 2026-01-08 13:11
Group 1 - The company Zhongzhong Technology announced the approval of its 2025 restricted stock incentive plan during the 12th meeting of its second board of directors [2] - The meeting included discussions on the initial grant of restricted stocks to the incentive objects of the plan [2] - The company is taking steps to implement a structured incentive program aimed at enhancing employee motivation and aligning interests with shareholders [2]
酉立智能:关于2025年限制性股票激励计划首次授予结果的公告
Zheng Quan Ri Bao· 2026-01-07 14:19
(文章来源:证券日报) 证券日报网讯 1月7日,酉立智能发布公告称,公司2025年限制性股票激励计划完成首次授予登记, 75.20万股于2026年1月6日登记至23名激励对象名下,授予价35.97元/股,占授予后总股本1.72%,限售 期12个月、24个月,2026、2027年业绩达标后分两批50%解锁。 ...
固德威:2026年1月7日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2026-01-07 11:35
每经头条(nbdtoutiao)——十年首现,沪指连续站稳关键位置!高盛:建议高配中国股票!券商分析 师:人民币升值等因素加速跨境资本回流 每经AI快讯,固德威1月7日晚间发布公告称,公司第四届第二次董事会会议于2026年1月7日在公司会 议室以现场与通讯表决相结合的方式召开。会议审议了《关于提请股东会授权董事会办理2026年限制性 股票激励计划相关事宜的议案》等文件。 (记者 张明双) ...
艾为电子:董事会同意向113人授予100万股限制性股票
Xin Lang Cai Jing· 2026-01-07 10:53
艾为电子公告称,董事会薪酬与考核委员会核查后认为,2025年限制性股票激励计划授予的113名激励 对象,与公司2026年第一次临时股东会批准的草案规定相符,且不存在不得成为激励对象的情形。激励 对象不包括独立董事、持股5%以上股东及其配偶等。委员会同意激励对象名单,确定授予日为2026年1 月7日,以41.35元/股的价格向激励对象授予100万股限制性股票。 ...
锦好医疗(920925)披露2025年限制性股票激励计划预留权益授予的激励对象名单,1月7日股价下跌14.76%
Sou Hu Cai Jing· 2026-01-07 09:48
Group 1 - The stock price of Jinhai Medical (920925) closed at 27.84 yuan on January 7, 2026, down 14.76% from the previous trading day, with a total market capitalization of 2.741 billion yuan [1] - The stock opened at 31.44 yuan, reached a high of 31.44 yuan, and a low of 27.38 yuan, with a trading volume of 5.17 billion yuan and a turnover rate of 32.59% [1] - Jinhai Medical announced a 2025 restricted stock incentive plan, granting a total of 200,000 shares to three incentive objects, with senior management Zhang Liang receiving 100,000 shares (50.00%), Yuan Jinpeng receiving 50,000 shares (25.00%), and core employee Zhong Mei receiving 50,000 shares (25.00%) [1]
盐津铺子食品股份有限公司 2026年第一次临时股东会决议公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:002847 证券简称:盐津铺子 公告编号:2026-002 盐津铺子食品股份有限公司 2、本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开情况 (一)会议召开日期和时间: 现场会议时间为:2026年1月6日下午15:00 网络投票时间为:通过深圳证券交易所交易系统进行网络投票的具体时间为:2026年1月6日上午9:15一 9:25,9:30一11:30,下午13:00-15:00;通过深圳证券交易所互联网投票系统投票的具体时间为:2026 年1月6日(现场股东会召开当日)上午9:15至当日下午15:00。 (二)现场会议召开地点:湖南省长沙市雨花区长沙大道运达中央广场写字楼A座,盐津铺子食品股份 有限公司总部行政会议室。 2026年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 特别提示: 1、本次股东会未出现否决议案的情形; (二)现场会议出席情况 参加本次股东会现场会议的股东、股东代表及委托代理人共计12人,代表股份170,197,238股,占公司有 表决权股 ...
浙江医药股份有限公司关于2025年限制性股票激励计划授予结果的公告
Core Viewpoint - Zhejiang Medicine Co., Ltd. has completed the grant registration of its 2025 Restricted Stock Incentive Plan, awarding 10.284 million shares of restricted stock to 865 participants at a price of 7.30 yuan per share [2][4][6]. Grant Details - Grant Date: November 26, 2025 [3] - Total Shares Granted: 10.244 million shares [4] - Number of Participants: 865, including directors, senior management, and key employees [5] - Grant Price: 7.30 yuan per share [6] - Source of Shares: Shares repurchased from the secondary market [7] Changes in Grant Numbers - The actual number of shares granted decreased from 10.284 million to 10.244 million due to 10 participants voluntarily waiving their rights to a total of 40,000 shares [8]. Registration and Lock-up Period - Registration Date for Restricted Shares: January 5, 2026 [10] - Lock-up Period: 12 months and 24 months for different tranches of shares [11] Performance Assessment - The performance assessment for unlocking the restricted shares will be based on company-level and individual-level evaluations over the 2026-2027 accounting years [12][15]. - Company-level assessments will be categorized into three tiers (A, B, C) based on various business segments [13]. Financial Impact - The funds raised from this incentive plan will be used to supplement the company's working capital [7]. - The accounting costs associated with the restricted stock will be recognized over the vesting period, with potential impacts on the company's financial results [18].
佛燃能源集团股份有限公司第六届董事会第二十六次会议决议公告
Group 1 - The company held its 26th meeting of the 6th Board of Directors on January 6, 2026, via telecommunication, with all 8 members present [1][3] - The Board approved the profit distribution plan for the first three quarters of 2025, proposing a cash dividend of 2.5 yuan per 10 shares, totaling 324,598,554.25 yuan [1][9] - The profit distribution plan is based on the current total share capital of 1,298,394,217 shares and will not include stock bonuses or capital reserve transfers [1][9] Group 2 - The Board believes the profit distribution plan complies with relevant laws and regulations, and it balances immediate and long-term shareholder interests [2][9] - The plan considers the company's profitability and operational development, ensuring it does not significantly impact cash flow or normal operations [2][9] - The distribution plan will be adjusted if there are changes in total share capital due to convertible bonds, share buybacks, or other reasons before implementation [2][9] Group 3 - The Board also approved an adjustment to the repurchase price of the initial grant of the 2023 restricted stock incentive plan, contingent on the profit distribution plan's implementation [4][20] - The adjustment method for the repurchase price is outlined, ensuring compliance with the incentive plan and relevant regulations [22][23] - The adjustment is not expected to materially affect the company's financial status, operational results, or stock distribution [24][25]